Recurrent macrophage activation syndrome due to hyperimmunoglobulin D syndrome: a case-based review-Reference-Cited by-同舟云学术

Recurrent macrophage activation syndrome due to hyperimmunoglobulin D syndrome: a case-based review

Published:2022-09-23 Issue:1 Volume:42 Page:277-283
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Gezgin Yıldırım Deniz^ORCID,Yıldız Yıldırım Çisem^ORCID,Karaçayır Nihal^ORCID,Esmeray Şenol Pelin^ORCID,Sunar Yayla Emine Nur^ORCID,Bakkaloğlu Sevcan A.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s10067-022-06384-9.pdf

Reference27 articles.

1. Zhang S (2016) Natural history of mevalonate kinase deficiency: a literature review. Pediatr Rheumatol Online J 14:30. https://doi.org/10.1186/s12969-016-0091-7

2. Drenth JP, Cuisset L, Grateau G, Vasseur C, van de Velde-Visser SD, de Jong JG, Beckman JS, van der Meer JW, Delpech M (1999) Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. Nat Genet 22:178–181. https://doi.org/10.1038/9696

3. Rigante D, Frediani B, Cantarini L (2018) A comprehensive overview of the hereditary periodic fever syndromes. Clin Rev Allergy Immunol 54:446–453. https://doi.org/10.1007/s12016-016-8537-8

4. van der Hilst JC, Bodar EJ, Barron KS, Frenkel J, Drenth JP, van der Meer JW, Simon A, International HIDS Study Group (2008) Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine (Baltimore) 87:301–310. https://doi.org/10.1097/MD.0b013e318190cfb7

5. ter Haar NM, Oswald M, Jeyaratnam J, Anton J, Barron KS, Brogan PA et al (2015) Recommendations for the management of autoinflammatory diseases. Ann Rheum Dis 74:1636–1644. https://doi.org/10.1136/annrheumdis-2015-207546

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on autoinflammatory diseases;Current Opinion in Rheumatology;2023-07-06

2. Advances in attractive therapeutic approach for macrophage activation syndrome in COVID-19;Frontiers in Immunology;2023-07-06